Cargando…

A Chinese female patient with LGI1 and mGluR5 antibodies: A case report

Anti-LGI1 antibody encephalitis and anti-mGluR5 are both uncommon encephalitis, and we report the first case of autoimmune encephalitis (AE) with dual seropositive antibodies of leucine-rich glioma-inactivated 1 (LGI1) and mGluR5. PATIENT CONCERNS: We present a case of AE with dual seropositive anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Tiantian, Luo, Xintong, Zhao, Jingru, Wang, Tianjun, Chen, Jinghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622628/
https://www.ncbi.nlm.nih.gov/pubmed/36316880
http://dx.doi.org/10.1097/MD.0000000000031063
_version_ 1784821815073308672
author Huo, Tiantian
Luo, Xintong
Zhao, Jingru
Wang, Tianjun
Chen, Jinghong
author_facet Huo, Tiantian
Luo, Xintong
Zhao, Jingru
Wang, Tianjun
Chen, Jinghong
author_sort Huo, Tiantian
collection PubMed
description Anti-LGI1 antibody encephalitis and anti-mGluR5 are both uncommon encephalitis, and we report the first case of autoimmune encephalitis (AE) with dual seropositive antibodies of leucine-rich glioma-inactivated 1 (LGI1) and mGluR5. PATIENT CONCERNS: We present a case of AE with dual seropositive antibodies of LGI1 and mGluR5 in a 65-year-old woman who presented with sudden onset left faciobrachial dystonic seizures and unresponsive for 5 hours. DIAGNOSIS: The patient was diagnosed with anti-LGI1 AE and anti-mGluR5 AE mainly based on the clinical symptoms and further test of the antibody in serum and cerebral spinal fluid (CSF). INTERVENTIONS AND OUTCOMES: The patient was treated with glucocorticoid intravenous drip. We also gave her the therapy of immunoglobulin (25 g q.d) for 5 days and anti-epileptic therapy. She had no more convulsions on the left side of the face and limbs. She did not complain of any uncomfort until July 18. LESSONS: Early recognition of AE is crucial. Specific autoantibodies are associated with corresponding syndromes. Our patient was initially diagnosed with acute ischemic stroke. Therefore, we should conduct further study on the related symptoms of AE.
format Online
Article
Text
id pubmed-9622628
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-96226282022-11-03 A Chinese female patient with LGI1 and mGluR5 antibodies: A case report Huo, Tiantian Luo, Xintong Zhao, Jingru Wang, Tianjun Chen, Jinghong Medicine (Baltimore) Research Article Anti-LGI1 antibody encephalitis and anti-mGluR5 are both uncommon encephalitis, and we report the first case of autoimmune encephalitis (AE) with dual seropositive antibodies of leucine-rich glioma-inactivated 1 (LGI1) and mGluR5. PATIENT CONCERNS: We present a case of AE with dual seropositive antibodies of LGI1 and mGluR5 in a 65-year-old woman who presented with sudden onset left faciobrachial dystonic seizures and unresponsive for 5 hours. DIAGNOSIS: The patient was diagnosed with anti-LGI1 AE and anti-mGluR5 AE mainly based on the clinical symptoms and further test of the antibody in serum and cerebral spinal fluid (CSF). INTERVENTIONS AND OUTCOMES: The patient was treated with glucocorticoid intravenous drip. We also gave her the therapy of immunoglobulin (25 g q.d) for 5 days and anti-epileptic therapy. She had no more convulsions on the left side of the face and limbs. She did not complain of any uncomfort until July 18. LESSONS: Early recognition of AE is crucial. Specific autoantibodies are associated with corresponding syndromes. Our patient was initially diagnosed with acute ischemic stroke. Therefore, we should conduct further study on the related symptoms of AE. Lippincott Williams & Wilkins 2022-10-28 /pmc/articles/PMC9622628/ /pubmed/36316880 http://dx.doi.org/10.1097/MD.0000000000031063 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Huo, Tiantian
Luo, Xintong
Zhao, Jingru
Wang, Tianjun
Chen, Jinghong
A Chinese female patient with LGI1 and mGluR5 antibodies: A case report
title A Chinese female patient with LGI1 and mGluR5 antibodies: A case report
title_full A Chinese female patient with LGI1 and mGluR5 antibodies: A case report
title_fullStr A Chinese female patient with LGI1 and mGluR5 antibodies: A case report
title_full_unstemmed A Chinese female patient with LGI1 and mGluR5 antibodies: A case report
title_short A Chinese female patient with LGI1 and mGluR5 antibodies: A case report
title_sort chinese female patient with lgi1 and mglur5 antibodies: a case report
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622628/
https://www.ncbi.nlm.nih.gov/pubmed/36316880
http://dx.doi.org/10.1097/MD.0000000000031063
work_keys_str_mv AT huotiantian achinesefemalepatientwithlgi1andmglur5antibodiesacasereport
AT luoxintong achinesefemalepatientwithlgi1andmglur5antibodiesacasereport
AT zhaojingru achinesefemalepatientwithlgi1andmglur5antibodiesacasereport
AT wangtianjun achinesefemalepatientwithlgi1andmglur5antibodiesacasereport
AT chenjinghong achinesefemalepatientwithlgi1andmglur5antibodiesacasereport
AT huotiantian chinesefemalepatientwithlgi1andmglur5antibodiesacasereport
AT luoxintong chinesefemalepatientwithlgi1andmglur5antibodiesacasereport
AT zhaojingru chinesefemalepatientwithlgi1andmglur5antibodiesacasereport
AT wangtianjun chinesefemalepatientwithlgi1andmglur5antibodiesacasereport
AT chenjinghong chinesefemalepatientwithlgi1andmglur5antibodiesacasereport